AVTX
AVTX
NASDAQ · Biotechnology

Avalo Therapeutics Inc

$7.76
+0.06 (+0.78%)
As of Nov 15, 10:34 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +324.1% upside
Low Target $27.78
Average Target $32.91
High Target $47.11
Current Price $7.76
Current
$7.76
Target
$32.91
$27.78 $32.91 avg $47.11
Scenario Analysis
Bear Case
$27.78
258.0%
Low target
Base Case
$32.91
+324.1%
Avg target
Bull Case
$47.11
+507.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$24.27
-68.0% from high
52-Week Low
$6.53
+18.8% from low
Target vs 52W High
$32.91
+35.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%